Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease
- PMID: 10562460
- DOI: 10.1006/mgme.1999.2904
Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease
Abstract
Mechanisms producing the divergent phenotypes, Wolman disease (WD) and cholesterol ester storage disease (CESD), associated with the genetic deficiency of human lysosomal acid lipase/cholesterol ester hydrolase (hLAL) function were investigated with the determination of HLAL activity levels, mRNA and protein expression, and defects in structural gene sequences in cells from three WD and five CESD patients. Measured with natural substrates, HLAL activities were all below 2% of normal, regardless of phenotype. Immunoblotting showed a lack of detectable hLAL protein in all mutant fibroblasts. Four CESD, but no WD genomes contained at least one allele with a specific exon 8 splice junction mutation, c.894 G>A, that encodes a shortened form of hLAL mRNA. Other CESD mutations were identical in type to the WD defects: nucleotide deletions (positions 397, 684, 980), insertions (594), or substitutions (193, 347) that result in premature terminations precluding any function. The only exception was a substitution at nucleotide 866 in the CESD case without an exon 8 splicing mutation; expression of the predicted S289C change in a transfection assay produced a low, but clearly measurable, level of acid esterase activity. Although it is not easily demonstrated in conventional assays, CESD is distinct from WD in that at least one mutant allele has the potential to produce enough residual enzymatic function to ameliorate the phenotype; in the majority of CESD cases this may come from a single, easily detected, splicing mutation in one allele.
Copyright 1999 Academic Press.
Similar articles
-
Molecular and enzymatic analyses of lysosomal acid lipase in cholesteryl ester storage disease.Mol Genet Metab. 1998 Jun;64(2):126-34. doi: 10.1006/mgme.1998.2707. Mol Genet Metab. 1998. PMID: 9705237 Review.
-
Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.Genomics. 1996 Apr 1;33(1):85-93. doi: 10.1006/geno.1996.0162. Genomics. 1996. PMID: 8617513
-
Different missense mutations in histidine-108 of lysosomal acid lipase cause cholesteryl ester storage disease in unrelated compound heterozygous and hemizygous individuals.Hum Mutat. 1998;12(1):44-51. doi: 10.1002/(SICI)1098-1004(1998)12:1<44::AID-HUMU7>3.0.CO;2-O. Hum Mutat. 1998. PMID: 9633819
-
A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease.J Clin Invest. 1993 Dec;92(6):2713-8. doi: 10.1172/JCI116888. J Clin Invest. 1993. PMID: 8254026 Free PMC article.
-
[Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease].Nihon Rinsho. 1995 Dec;53(12):3004-8. Nihon Rinsho. 1995. PMID: 8577049 Review. Japanese.
Cited by
-
Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance.J Hepatol. 2013 Sep;59(3):543-9. doi: 10.1016/j.jhep.2013.04.016. Epub 2013 Apr 25. J Hepatol. 2013. PMID: 23624251 Free PMC article.
-
Cholesterol ester storage disease (CESD) diagnosed in an asymptomatic adult.Dig Dis Sci. 2009 Jan;54(1):168-73. doi: 10.1007/s10620-008-0310-2. Epub 2008 May 14. Dig Dis Sci. 2009. PMID: 18478331 Review. No abstract available.
-
Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency.J Hepatol. 2014 Nov;61(5):1135-42. doi: 10.1016/j.jhep.2014.06.022. Epub 2014 Jun 30. J Hepatol. 2014. PMID: 24993530 Free PMC article. Clinical Trial.
-
Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups.Hepatology. 2013 Sep;58(3):958-65. doi: 10.1002/hep.26327. Epub 2013 Jul 29. Hepatology. 2013. PMID: 23424026 Free PMC article.
-
Combined hyperlipidaemia as a presenting sign of cholesteryl ester storage disease.J Inherit Metab Dis. 2009 Dec;32 Suppl 1:S11-3. doi: 10.1007/s10545-008-1027-2. Epub 2009 Feb 15. J Inherit Metab Dis. 2009. PMID: 19214773
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources